Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load

Obstetrics and Gynecology

Volumn 96, Issue 3, 2000, Pages 403-409

  Heard, Isabelle ^a,c   Tassie, Jean Michel ^a,b   Schmitz, Valerie ^a,b   Mandelbrot, Laurent ^a,b   Kazatchkine, Michel D ^a,b   Orth, Gérard ^a,b  

^a HÔPITAL BROUSSAIS   (France)

^b Unité Mixte Institut PasteurINSERM U190 ^*  (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BEHAVIOR; DNA DETERMINATION; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SOUTHERN BLOTTING; UTERINE CERVIX DISEASE; VIRUS LOAD; VIRUS PATHOGENESIS; WART VIRUS;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; RNA VIRUSES;

EID: 0034734966     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-200009000-00016     Document Type: Article

References (39)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Janscn AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76:1888-901.
3. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotypes as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996;69:364-8.
4. Remmink AJ, \Valboomers JMM, Heimerhorst TJM, Voorhorst FJ, Rozendaal L, Risse EKJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer 1995;61:306-11.
5. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:136571.
6. Ho GYF, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, et al. Viral characteristics of human papiltomavims infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998;78:594-9.
7. Alloub Ml, Barr BBB, McLaren KM, Smith IVV, Bunney MH, Smart GE. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 19S9;298:153-6.
8. Vermund SH, Melnick SL. Human papillomavirus infection. In: Minkoff HL, DeHovitz JA, Duerr A, eds. HIV infection in women. New York: Raven, 1995:189-227.
9. Vermund SH, Kelley KF, Klein RS, Feingold AR, Schreiber K, Munk G, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynccol 1991;165:392-400.
10. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW, Brudney K, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
11. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-6.
12. Schäfer A, Friedmann W, Mielke M, Schwartländer B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164: 593-9.
13. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HlV)-positive and high-risk HIVnegative women. J Natl Cancer Inst 1999;91:226-36.
14. Sun XVV, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in human immunodeficiency virus-séropositive women. Obstet Gynecol 1995;85:680-6.
15. Sun XW, Kühn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Mod 1997;337:1343-9.
16. Minkoff H, Feldman J, De Hovitz ], Landesman S, Burk R. A longiludinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998;178:982-6.
17. Klein RS, Ho GYF, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994;170:1404-9.
18. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83: 205-11.
19. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1999;21:3341.
20. Mandelblatt JS, Kanetsky P, Eggert L, Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 1999;8:97-106.
21. Stafl A, Wilbanks GD. An international terminology of colposcopy: Report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet Gynecol 1991;77:313-4.
22. Ting Y, Manos MM. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR protocols: A guide to methods and applications. San Diego: Academic Press, 1990:356-67.
23. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998;159:86-9.
24. Bauer HM, Ting Y, Gréer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265: 472-7.
25. de Roda Husman AM, Walboomers JMM, van den Bruke AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3' ends \vith adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995,76:1057-62.
26. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Ann Intern Med 1997;127:922-46.
27. Seek AC, Faye MA, Critchlow CW, Mbaye AD, Kuypers J, WotoGaye G, et al. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for H1V. Int J STD AIDS 1994;5: 189-93.
28. Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Ryder RW, et al. Genital papillomavirus infection and cervical dysplasia: Opportunistic complications of HIV infection. Int J Cancer 1992; 50:45-8.
29. Goldberg GL, Vermund SH, Schiffman MH, Ritter DB, Spitzer C, Burk RD. Comparison of cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus. Am J Obstet Gynecol 1989;161:1669-72.
30. Ho GYF, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56: 788-92.
31. Heard I, Jeannel D, Bergeron C, Saada M, Henrion R, Kazatchkine MD. Lack of behavioral risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women. Int J STD AIDS 1997;8:38892.
32. Melbye M, Smith E, Wohlfahrt }, Osterlind A, Orholm M, Bergmann OJ, et al. Anal and cervical abnormality in women: Prediction by human papillomavims tests. Int J Cancer 1996;68:559-64.
33. Heard I, Schmilz V, Costagliola D, Orth G, Kazatchkine M. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998;12:1459-64.
34. Nuovo GJ, Forde A, MacConnell P, Fahrenwald R. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol 1993;143:40-8.
35. Mostad SB, Kreiss JK. Shedding of HIV-1 in the genital tract. AIDS 1996;10:1305-15.
36. Braun L. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia. Am J Pathol 1994;144:209-14.
37. Malejczyk J, Malejczyk M, Köck A, Urbanski A, Majewski S, Hunzelmann N, et al. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-. J Immunol 1992;149:2702-8.
38. Rosl F, Kleine-Lowinski K, zur Hausen H. The possible role of chemokines in HPV-linked carcinogenesis. In: Rollins BJ, ed. Chemokines and cancer. Totowa, New Jersey: Humana Press, 1999;207-25.
39. Arany I, Tyring SK. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum. Int J STD AIDS 1998;9:268-71.